Metraipolis › archive › dc_8d66dbe4dcea

Combined mesenchymal stem cells and metformin therapy modulates key macromolecular pathways in pulmonary fibrosis based on evidence from untargeted metabolomics — Europe PMC PMID:42031850

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42031850
DOI
10.1038/s41598-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-03T06:05:54.402Z
SHA-256 of the archived text
54534bf3753242037959c6081c7eec15d1165ffabd113445518c5602d4f4e08f
Stable URL of this page
https://metraipolis.com/documento/dc_8d66dbe4dcea

How to cite

Combined mesenchymal stem cells and metformin therapy modulates key macromolecular pathways in pulmonary fibrosis based on evidence from untargeted metabolomics — Europe PMC PMID:42031850 — Europe PMC (en), https://europepmc.org/article/MED/42031850 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d66dbe4dcea (Metraipolis archive dc_8d66dbe4dcea, sha256 54534bf3753242037959c6081c7eec15d1165ffabd113445518c5602d4f4e08f)
BibTeX
@misc{dc8d66dbe4dcea,
  title = {Combined mesenchymal stem cells and metformin therapy modulates key macromolecular pathways in pulmonary fibrosis based on evidence from untargeted metabolomics — Europe PMC PMID:42031850},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42031850},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d66dbe4dcea; sha256 54534bf3753242037959c6081c7eec15d1165ffabd113445518c5602d4f4e08f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42031850. Agents can read the archived copy with the MCP tool read_document.